Literature DB >> 9279451

Cross-sectional and longitudinal changes in total and high-density-lipoprotein cholesterol levels over a 20-year period in elderly men: the Honolulu Heart Program.

R D Abbott1, D S Sharp, C M Burchfiel, J D Curb, B L Rodriguez, A A Hakim, K Yano.   

Abstract

PURPOSE: The purpose of this report is to describe levels of total cholesterol and high-density-lipoprotein cholesterol (HDL-C) in a group of elderly men and to compare these levels to those that were observed 20 years earlier.
METHODS: From 1965-1968, the Honolulu Heart Program began following 8006 men of Japanese ancestry living on the island of Oahu, Hawaii, in a prospective study of coronary heart disease and stroke. This report presents data for 971 men who participated in a separate fasting study of lipids and lipoproteins that first occurred from 1970-1972 and in those who received repeat examinations 10 and 20 years later. Men were aged 71-93 years at the last examination.
RESULTS: Over the 20-year period, total cholesterol declined by 1.6-1.8 mg/dL per year (P < 0.001), from average baseline values of 219-222 mg/dL. Levels of HDL-C rose 0.2-0.3 mg/dL per year (P < 0.001), from average baseline values of 44-46 mg/dL. After adjustment for baseline cholesterol levels, men with prevalent coronary heart disease at the end of the 20-year follow-up experienced significantly greater reductions in total cholesterol levels than men without disease (P < 0.001). Men who developed coronary heart disease within the first 10 years of follow-up had the greatest yearly decline in total cholesterol (1.9 mg/dL), followed by men who developed heart disease later (1.8 mg/dL) and men who remained disease free (1.5 mg/dL). Differences between men with recent and earlier disease were not statistically significant, although men without coronary disease experienced a significantly smaller decrease in total cholesterol than either of these groups (P < 0.05).
CONCLUSIONS: Changes in total cholesterol and HDL-C levels with advancing age may be part of a natural aging process. Some changes, however, such as large reductions in total cholesterol, may signal occult disease or declines in overall health. Selective survival may contribute to these findings since improvements in lipid and lipoprotein levels that are beneficial in younger ages were common in this long-lived cohort of men.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9279451     DOI: 10.1016/s1047-2797(97)00043-4

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  9 in total

1.  Invited commentary: lipoproteins and dementia - is it the apolipoprotein A-I?

Authors:  Nikolaos Scarmeas
Journal:  Am J Epidemiol       Date:  2007-02-13       Impact factor: 4.897

2.  Modifiable disease risk, readiness to change, and psychosocial functioning improve with integrative medicine immersion model.

Authors:  Ruth Q Wolever; Daniel M Webber; Justin P Meunier; Jeffrey M Greeson; Evangeline R Lausier; Tracy W Gaudet
Journal:  Altern Ther Health Med       Date:  2011 Jul-Aug       Impact factor: 1.305

3.  The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer.

Authors:  Donovan McGrowder; Cliff Riley; Errol Y St A Morrison; Lorenzo Gordon
Journal:  Cholesterol       Date:  2010-12-23

4.  Cognitive impairment and Alzheimer's disease: Links with oxidative stress and cholesterol metabolism.

Authors:  Alejandra Sekler; José M Jiménez; Leonel Rojo; Edgard Pastene; Patricio Fuentes; Andrea Slachevsky; Ricardo B Maccioni
Journal:  Neuropsychiatr Dis Treat       Date:  2008-08       Impact factor: 2.570

5.  Longitudinal trajectories of cholesterol from midlife through late life according to apolipoprotein E allele status.

Authors:  Brian Downer; Steven Estus; Yuriko Katsumata; David W Fardo
Journal:  Int J Environ Res Public Health       Date:  2014-10-16       Impact factor: 4.614

6.  Longitudinal and secular trends in total cholesterol levels and impact of lipid-lowering drug use among Norwegian women and men born in 1905-1977 in the population-based Tromsø Study 1979-2016.

Authors:  Laila Arnesdatter Hopstock; Kaare Harald Bønaa; Anne Elise Eggen; Sameline Grimsgaard; Bjarne K Jacobsen; Maja-Lisa Løchen; Ellisiv B Mathiesen; Inger Njølstad; Tom Wilsgaard
Journal:  BMJ Open       Date:  2017-08-21       Impact factor: 2.692

7.  Association of insulin resistance, from mid-life to late-life, with aortic stiffness in late-life: the Atherosclerosis Risk in Communities Study.

Authors:  Anna K Poon; Michelle L Meyer; Hirofumi Tanaka; Elizabeth Selvin; James Pankow; Donglin Zeng; Laura Loehr; Joshua W Knowles; Wayne Rosamond; Gerardo Heiss
Journal:  Cardiovasc Diabetol       Date:  2020-01-28       Impact factor: 9.951

8.  Exome sequence association study of levels and longitudinal change of cardiovascular risk factor phenotypes in European Americans and African Americans from the Atherosclerosis Risk in Communities Study.

Authors:  Elena V Feofanova; Elise Lim; Han Chen; MinJae Lee; Ching-Ti Liu; L Adrienne Cupples; Eric Boerwinkle
Journal:  Genet Epidemiol       Date:  2021-06-24       Impact factor: 2.344

9.  Biochemical alterations during the obese-aging process in female and male monosodium glutamate (MSG)-treated mice.

Authors:  René J Hernández-Bautista; Francisco J Alarcón-Aguilar; María Del C Escobar-Villanueva; Julio C Almanza-Pérez; Héctor Merino-Aguilar; Mina Konigsberg Fainstein; Norma E López-Diazguerrero
Journal:  Int J Mol Sci       Date:  2014-06-27       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.